Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06
暂无分享,去创建一个
John Sidney | Alessandro Sette | Carrie Moore | J. Sidney | A. Sette | J. Shabanowitz | D. Hunt | Amanda Wriston | T. DiLorenzo | Mikaela Lindvall | Jeffrey Shabanowitz | Teresa P. DiLorenzo | Donald F. Hunt | Jennifer Schloss | Amanda Wriston | Carrie Moore | Jennifer Schloss | Mikaela Lindvall
[1] A Sette,et al. The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. , 2001, Biologicals : journal of the International Association of Biological Standardization.
[2] J. Granados,et al. Intron 2 and exon 3 sequences may be involved in the susceptibility to develop Takayasu arteritis. , 1998, International journal of cardiology.
[3] P. A. Peterson,et al. Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.
[4] H. Rammensee,et al. Peptide motifs of HLA-B38 and B39 molecules , 2004, Immunogenetics.
[5] E. Yunis,et al. Association of HLA-DRB1*1602 and DRB1*1001 with Takayasu arteritis in Colombian mestizos as markers of Amerindian ancestry. , 2000, International journal of cardiology.
[6] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[7] E. Leiter,et al. Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant , 1994, Diabetes.
[8] J. Shabanowitz,et al. Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. , 2010, International immunology.
[9] D. Vignali,et al. T cell-driven initiation and propagation of autoimmune diabetes. , 2011, Current opinion in immunology.
[10] N. Rezaei,et al. Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris , 2013, The Journal of dermatology.
[11] A. Sette,et al. Epitope-based vaccines: an update on epitope identification, vaccine design and delivery. , 2003, Current opinion in immunology.
[12] S. Baranzini,et al. Genetic contribution to multiple sclerosis risk among Ashkenazi Jews , 2015, BMC Medical Genetics.
[13] Bjoern Peters,et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.
[14] J. Carlson,et al. HLA Class I and Genetic Susceptibility to Type 1 Diabetes , 2010, Diabetes.
[15] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[16] P. Santamaria,et al. CD8+ T cells in autoimmunity. , 2005, Current opinion in immunology.
[17] M Peakman,et al. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06. , 2014, Tissue antigens.
[18] D. Clayton,et al. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA‐B and HLA‐A , 2009, Diabetes, obesity & metabolism.
[19] J. Rosmalen,et al. T-cell education in autoimmune diabetes: teachers and students. , 2002, Trends in immunology.
[20] Morten Nielsen,et al. A Community Resource Benchmarking Predictions of Peptide Binding to MHC-I Molecules , 2006, PLoS Comput. Biol..
[21] Alessandro Sette,et al. Reverse vaccinology: developing vaccines in the era of genomics. , 2010, Immunity.
[22] Simon C. Potter,et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A , 2007, Nature.
[23] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[24] Clemencia Pinilla,et al. Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.
[25] K. Frauwirth,et al. Peripheral tolerance in CD8+ T cells. , 2009, Cytokine.
[26] Magdalini Moutaftsi,et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus , 2006, Nature Biotechnology.
[27] M. Soto,et al. Comparative study of the residues 63 and 67 on the HLA-B molecule in patients with Takayasu's Arteritis. , 2005, Immunology letters.
[28] A Sette,et al. Tools of the Trade in Vaccine Design , 2000, Science.
[29] M. Atkinson,et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients , 2012, The Journal of experimental medicine.
[30] Bjoern Peters,et al. Immune epitope mapping in the post-genomic era: lessons for vaccine development. , 2007, Current opinion in immunology.
[31] John Sidney,et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Sewell,et al. Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity , 2012, Diabetes.
[33] Meenu R Pillai,et al. The development and function of regulatory T cells , 2009, Cellular and Molecular Life Sciences.
[34] J. Sidney,et al. The role of MHC class I allele Mamu-A*07 during SIVmac239 infection , 2011, Immunogenetics.
[35] Michel C Nussenzweig,et al. Tolerogenic dendritic cells. , 2003, Annual review of immunology.
[36] Morten Nielsen,et al. Automated benchmarking of peptide-MHC class I binding predictions , 2015, Bioinform..
[37] T. DiLorenzo,et al. Glucagon‐reactive islet‐infiltrating CD8 T cells in NOD mice , 2015, Immunology.